Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 2Sarcoma 1Head & Neck 1Genitourinary 1

Conditions

Sarcoma 7Nasopharyngeal Carcinoma 2Liposarcoma 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Ovarian Neoplasms 1Melanoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 5Specimen Handling 5Nivolumab 5Cyclophosphamide 5Magnetic Resonance Spectroscopy 4Bevacizumab 4Oxaliplatin 3Leucovorin 3Cisplatin 3sargramostim 2fludarabine 2cabozantinib 2aflibercept 2X-Rays 2Stem Cell Transplantation 2Sirolimus 2Paclitaxel 2Mesna 2Melphalan 2Irinotecan 2Ipilimumab 2Ifosfamide 2Fluorouracil 2Fluorodeoxyglucose F18 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Doxorubicin 2Cryosurgery 2Busulfan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × toripalimab × Sarcoma × Clear all
NCT03474640 2024-11-22

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

TopAlliance Biosciences

Phase 1 Completed
184 enrolled 20 charts
GastrointestinalHead & NeckSarcoma

Nasopharyngeal Carcinoma, Chondrosarcoma, Esophageal Neoplasms, Carcinoma, Hepatocellular, Sarcoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡